Virology, Emerging Diseases and Vaccines

Andrea Borns, microbiologist and respiratory therapist who holds a Master’s of Public Health is the founder and Chief Executive Officer of ZEN Clinical and Bioscience. ZEN is a newly-formed consulting and laboratory client-driven research and development (R&D) company in the field of bacteriophage therapy and phage biotechnology to address emerging infectious and neglected tropical diseases. Originally from Brazil, Andrea started her career in Biomedical Sciences and was involved in HIV/AIDS research during the late ’90s in Rio de Janeiro. She is also a former Assistant Professor and Director of Clinical Education at the University of the District of Columbia, USA, where she worked closely with lung diseases, critical care, and mechanical ventilation before her comeback to the bench.

Marina Sidorenko has completed his PhD in two specialties: soil science and microbiology. She is a leading researcher at the FSCEATB FEB RAS. She has published over 35 articles in well-known journals and 4 patents of the Russian Federation, is a member of the editorial board and reviewer of several journals. Her areas of interest are applied microbiology, soil microbiome, sanitary microbiology. Vladislav Sidorenko is a student of PRMU. She has a 3 articles in scientific journal. Hers scientific interests: medical microbiology, epidemiology, infectious diseases.